Normunity (Series B)

Funding Details
Awarder
Inbox
Date Award
January 13, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$75,000,000

Company Info
Founders
Rachel Humphrey
Company Description
Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
Market
Anti-cancer therapies
Location
New Haven, Connecticut, USA
Coinvestors
Canaan Partners, Connecticut Innovations, Enavate Sciences, Hong Kong Inno Capital, HongShan Capital Group, Osage Venture Partners, Pfizer Venture Investments, Regeneron Ventures, Samsara BioCapital, Sanofi Ventures, Taiho Ventures, YK Bioventures

Links